Evidence map›Paper›PMID 28696004›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2018

Frequent loss of inositol polyphosphate-5-phosphatase in oropharyngeal squamous cell carcinoma.

A B Patel, A R Mangold, C M Costello, T H Nagel, M L Smith, R E Hayden, A Sekulic

Open access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Inhibitory activity of medicinal mushroomPrecision clinical medicine · 2021
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cutaneous Oncology: Strategies for Melanoma Prevention, Diagnosis, and Therapy.Cancer control : journal of the Moffitt Cancer Center
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

A B PatelDepartment of Otolaryngology, Head and Neck Surgery, Mayo Clinic, Phoenix, AZ, USA.
A R MangoldDepartment of Dermatology, Mayo Clinic, Scottsdale, AZ, USA.
C M CostelloDepartment of Dermatology, Mayo Clinic, Scottsdale, AZ, USA.
T H NagelDepartment of Otolaryngology, Head and Neck Surgery, Mayo Clinic, Phoenix, AZ, USA.
M L SmithDepartment of Pathology, Mayo Clinic, Phoenix, AZ, USA.
R E HaydenDepartment of Otolaryngology, Head and Neck Surgery, Mayo Clinic, Phoenix, AZ, USA.
A SekulicDepartment of Dermatology, Mayo Clinic, Scottsdale, AZ, USA.
Mayo Clinic Hospital · USMayo Clinic in Arizona · USMayo Clinic in Florida · US

Funding

Novel Therapeutics Targeting INPP5A Pathway in Squamous Cell CarcinomaR01CA179157 · NCI · MAYO CLINIC ARIZONA · PI SEKULIC, ALEKSANDAR NONE · 2014 to 2018
$1.8M
NCI NIH HHS R01 CA179157
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Squamous CellHumansImmunohistochemistryInositol Polyphosphate 5-PhosphatasesLymphatic MetastasisLymph NodesOropharyngeal NeoplasmsRespiratory MucosaInositol Polyphosphate 5-PhosphatasesINPP5A protein, human

Identifiers

PMID28696004
PMCPMC5990272
OpenAlexW2735604939

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.